Literature DB >> 14555953

Language fMRI abnormalities associated with FOXP2 gene mutation.

Frédérique Liégeois1, Torsten Baldeweg, Alan Connelly, David G Gadian, Mortimer Mishkin, Faraneh Vargha-Khadem.   

Abstract

Half the members of the KE family suffer from a speech and language disorder caused by a mutation in the FOXP2 gene. We examined functional brain abnormalities associated with this mutation using two fMRI language experiments, one involving covert (silent) verb generation and the other overt (spoken) verb generation and word repetition. The unaffected family members showed a typical left-dominant distribution of activation involving Broca's area in the generation tasks and a more bilateral distribution in the repetition task, whereas the affected members showed a more posterior and more extensively bilateral pattern of activation in all tasks. Consistent with previously reported bilateral morphological abnormalities, the affected members showed significant underactivation relative to the unaffected members in Broca's area and its right homolog, as well as in other cortical language-related regions and in the putamen. Our findings suggest that the FOXP2 gene is critically involved in the development of the neural systems that mediate speech and language.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555953     DOI: 10.1038/nn1138

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  94 in total

1.  Early and late talkers: school-age language, literacy and neurolinguistic differences.

Authors:  Jonathan L Preston; Stephen J Frost; William Einar Mencl; Robert K Fulbright; Nicole Landi; Elena Grigorenko; Leslie Jacobsen; Kenneth R Pugh
Journal:  Brain       Date:  2010-08       Impact factor: 13.501

Review 2.  Human brain evolution: from gene discovery to phenotype discovery.

Authors:  Todd M Preuss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-20       Impact factor: 11.205

3.  Symbolic representations in motor sequence learning.

Authors:  J Bo; S J Peltier; D C Noll; R D Seidler
Journal:  Neuroimage       Date:  2010-08-18       Impact factor: 6.556

4.  Human-specific increase of dopaminergic innervation in a striatal region associated with speech and language: A comparative analysis of the primate basal ganglia.

Authors:  Mary Ann Raghanti; Melissa K Edler; Alexa R Stephenson; Lakaléa J Wilson; William D Hopkins; John J Ely; Joseph M Erwin; Bob Jacobs; Patrick R Hof; Chet C Sherwood
Journal:  J Comp Neurol       Date:  2015-12-29       Impact factor: 3.215

5.  Word and nonword repetition in bilingual subjects: a PET study.

Authors:  Denise Klein; Kate E Watkins; Robert J Zatorre; Brenda Milner
Journal:  Hum Brain Mapp       Date:  2006-02       Impact factor: 5.038

6.  The role of the basal ganglia and cerebellum in language processing.

Authors:  James R Booth; Lydia Wood; Dong Lu; James C Houk; Tali Bitan
Journal:  Brain Res       Date:  2006-12-26       Impact factor: 3.252

7.  Neurophysiology of speech differences in childhood apraxia of speech.

Authors:  Jonathan L Preston; Peter J Molfese; Nina Gumkowski; Andrea Sorcinelli; Vanessa Harwood; Julia R Irwin; Nicole Landi
Journal:  Dev Neuropsychol       Date:  2014       Impact factor: 2.253

8.  Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells.

Authors:  Eriko Fujita; Yuko Tanabe; Akira Shiota; Masatsugu Ueda; Kiyotaka Suwa; Mariko Y Momoi; Takashi Momoi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Generation of mice with a conditional Foxp2 null allele.

Authors:  Catherine A French; Matthias Groszer; Christopher Preece; Anne-Marie Coupe; Klaus Rajewsky; Simon E Fisher
Journal:  Genesis       Date:  2007-07       Impact factor: 2.487

10.  Striatal FoxP2 is actively regulated during songbird sensorimotor learning.

Authors:  Ikuko Teramitsu; Amy Poopatanapong; Salvatore Torrisi; Stephanie A White
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.